Skip to main content
. 2017 Nov 9;22(45):17-00137. doi: 10.2807/1560-7917.ES.2017.22.45.17-00137

Table 1. Legionella pneumophila serogroup 1 samples and isolates used for the retrospective analysis of a 2013 Legionnaires’ disease outbreak by core genome multilocus sequence typing, Germany (n = 45).

Sample ID / source (C/E)a Epidemiological context to outbreak Culture Monoclonal subgroupb STc Allelic profile
(flaA, pilE, asd, mip, mompS, proA, neuA)
Outbreak clusterd
L13–435 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
L13–438 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
L13–439 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
L13–444 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
L13–445/-446 (C)e Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
L13–473 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
L13–477 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–845–1 (E) Cooling tower, source A, Warstein outbreak  + Knoxville 600 6, 10, 19, 28, 19, 4, 11 NAf
W13–845–4 (E) Cooling tower, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–845–8 (E) Cooling tower, source A, Warstein outbreak  + Knoxville 600 6, 10, 19, 28, 19, 4, 11 NAf
W13–871–1 (E) Condenser, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–873–1 (E) Pump shaft, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–874–15 (E) Pump shaft, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–875–15 (E) River inlet, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–875–17 (E) River inlet, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–876–13 (E) Aeration basin, source C, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–878–1 (E) River water, source D, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–879–1 (E) River water, source D, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–952–4 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–953–3 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W13–953–4 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W13–954–3 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W13–957–2 (E) Outlet, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–959–3 (E) Aeration basin, source C, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W13–959–4 (E) Inlet from source B, source C, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W13–1093 (E) Cooling tower, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–1096–2 (E) Cooling tower, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W14–178 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W14–472 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W14–474 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W14–476 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W14–489 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
P13–308 (C) Clinical sample, Warstein outbreak - NDf 345 6, 10, 19, 3, 19, 4, 11 NAg
P13–402 (C) Clinical sample, Warstein outbreak - NDf ND 6, 10, 0, 3, 0, 4, 11 NAg
P13–733 (C) Clinical sample, Warstein outbreak - NDf 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV1461 (C) Unrelated isolate (France)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV1647 (E) Unrelated isolate (the Netherlands)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV1654 (C) Unrelated isolate (the Netherlands)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV3674 (C) Unrelated isolate (the Netherlands)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV5358 (C) Unrelated isolate (France)  + OLDA 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV6345 (C) Unrelated isolate (France)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV9125 (C) Unrelated isolate (France)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
Corby (C) Unrelated isolate (United Kingdom)  + Knoxville 51 6, 10, 15, 28, 9, 14, 6 NAg
Alcoy 2300/99 (C) Unrelated isolate (Spain)  + Knoxville 578 6, 10, 15, 13, 9, 14, 6 NAg

C: clinical sample; E: environmental sample; ID: identity; NA: not applicable; ND: not determined; ST: sequence type.

a Source of sample: C corresponds to clinical isolates; E corresponds to environmental isolates.

b Monoclonal subgrouping as described by Helbig et al. [9].

c Sequence-based typing by using Sanger sequencing according to the ESCMID Study Group for Legionella Infections (ESGLI) protocol [10].

d Outbreak ST345 strain cluster assignment by core genome multilocus sequence typing.

e Isolates L13–445/-446 were isolated from the same patient.

f The molecular antibody-subgroup and/or sequence type were/was not determined because no isolate was obtained and/or because of incomplete direct sequence-based typing.

g Cluster assignment within the ST345 outbreak strain was not applicable when the isolate was from a chosen non-outbreak reference strain, when the isolate had another ST than ST345, or when no isolate could be obtained.